|
2018-01-04 |
2018-01-02 |
PS
Planned sale
|
Davis J. E.
EVP, General Diagnostics
Officer
|
63,880
-62.7%
98.68
6,303,359
USD
|
63,880
-62.7%
|
98.68
|
6,303,359
USD
|
|
|
2017-09-13 |
2017-09-12 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, President and CEO
Executive Director
|
5,302
-3.1%
108.12
573,236
USD
|
5,302
-3.1%
|
108.12
|
573,236
USD
|
|
|
2017-09-13 |
2017-09-11 |
S
Sale
|
STANZIONE DANIEL
|
40,900
-54.1%
108.07
4,419,940
USD
|
40,900
-54.1%
|
108.07
|
4,419,940
USD
|
|
|
2017-09-13 |
2017-09-11 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, President and CEO
Executive Director
|
53,933
-24.5%
108.16
5,833,609
USD
|
53,933
-24.5%
|
108.16
|
5,833,609
USD
|
|
|
2017-09-07 |
2017-09-05 |
PS
Planned sale
|
RUSCKOWSKI STEPHEN H
Chairman, President and CEO
Executive Director
|
2,525
-1.5%
108.03
272,768
USD
|
2,525
-1.5%
|
108.03
|
272,768
USD
|
|
|
2017-09-07 |
2017-09-05 |
PS
Planned sale
|
STANZIONE DANIEL
|
3,803
-9.9%
108.01
410,762
USD
|
3,803
-9.9%
|
108.01
|
410,762
USD
|
|
|
2017-08-08 |
2017-08-04 |
S
Sale
|
LEIDEN JEFFREY M
|
296
-4.7%
106.66
31,571
USD
|
296
-4.7%
|
106.66
|
31,571
USD
|
|
|
2017-07-31 |
2017-07-27 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
1,304
-17.2%
108.73
141,783
USD
|
1,304
-17.2%
|
108.73
|
141,783
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
2,559
-3.4%
108.13
276,715
USD
|
2,559
-3.4%
|
108.13
|
276,715
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
61,321
-44.7%
107.53
6,593,786
USD
|
61,321
-44.7%
|
107.53
|
6,593,786
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
1,158
-0.8%
108.14
125,223
USD
|
1,158
-0.8%
|
108.14
|
125,223
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
28,182
-16.9%
107.53
3,030,326
USD
|
28,182
-16.9%
|
107.53
|
3,030,326
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
336
-0.2%
108.15
36,338
USD
|
336
-0.2%
|
108.15
|
36,338
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Cohen Jon R
SVP & Group Exec. Diag. Sol.
|
13,344
-7.4%
107.52
1,434,747
USD
|
13,344
-7.4%
|
107.52
|
1,434,747
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
177
-0.3%
108.15
19,143
USD
|
177
-0.3%
|
108.15
|
19,143
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
6,418
-8.4%
107.54
690,217
USD
|
6,418
-8.4%
|
107.54
|
690,217
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
1,364
-1.8%
108.14
147,504
USD
|
1,364
-1.8%
|
108.14
|
147,504
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
42,636
-35.5%
107.52
4,584,223
USD
|
42,636
-35.5%
|
107.52
|
4,584,223
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
315
-0.3%
108.16
34,069
USD
|
315
-0.3%
|
108.16
|
34,069
USD
|
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
|
8,852
-6.9%
107.54
951,962
USD
|
8,852
-6.9%
|
107.54
|
951,962
USD
|
|
|
2017-04-26 |
2017-04-24 |
S
Sale
|
BRITELL JENNE K
|
6,111
-23.5%
104.03
635,727
USD
|
6,111
-23.5%
|
104.03
|
635,727
USD
|
|
|
2017-04-24 |
2017-04-20 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
28,500
-41.4%
100.00
2,850,000
USD
|
28,500
-41.4%
|
100.00
|
2,850,000
USD
|
|
|
2017-04-24 |
2017-04-20 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
1,013
-2.5%
100.00
101,300
USD
|
1,013
-2.5%
|
100.00
|
101,300
USD
|
|
|
2017-03-20 |
2017-03-16 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
13,987
-25.8%
100.00
1,398,700
USD
|
13,987
-25.8%
|
100.00
|
1,398,700
USD
|
|
|
2017-03-06 |
2017-03-03 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
4,478
-10.0%
98.29
440,143
USD
|
4,478
-10.0%
|
98.29
|
440,143
USD
|
|
|
2017-03-06 |
2017-03-03 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
6,028
-7.5%
98.29
592,492
USD
|
6,028
-7.5%
|
98.29
|
592,492
USD
|
|
|
2017-03-06 |
2017-03-02 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Group Exec. Clin. Fran.
Officer
|
1,134
-1.4%
98.25
111,416
USD
|
1,134
-1.4%
|
98.25
|
111,416
USD
|
|
|
2017-03-03 |
2017-03-01 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
470
-1.2%
97.77
45,952
USD
|
470
-1.2%
|
97.77
|
45,952
USD
|
|
|
2017-02-28 |
2017-02-27 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
440
-1.1%
97.39
42,852
USD
|
440
-1.1%
|
97.39
|
42,852
USD
|
|
|
2017-02-24 |
2017-02-22 |
S
Sale
|
ZIEGLER JOHN B
Non-Executive Director
|
2,000
-10.8%
95.51
191,016
USD
|
2,000
-10.8%
|
95.51
|
191,016
USD
|
|
|
2017-02-17 |
2017-02-15 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
1,615
-2.2%
94.65
152,858
USD
|
1,615
-2.2%
|
94.65
|
152,858
USD
|
|
|
2017-02-15 |
2017-02-13 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
1,200
-2.9%
93.76
112,512
USD
|
1,200
-2.9%
|
93.76
|
112,512
USD
|
|
|
2017-02-06 |
2017-02-02 |
S
Sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
15,000
-26.3%
92.38
1,385,745
USD
|
15,000
-26.3%
|
92.38
|
1,385,745
USD
|
|
|
2017-02-06 |
2017-02-02 |
S
Sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
30,000
-41.7%
92.40
2,771,850
USD
|
30,000
-41.7%
|
92.40
|
2,771,850
USD
|
|
|
2017-02-01 |
2017-01-30 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
37,414
-32.8%
90.40
3,382,076
USD
|
37,414
-32.8%
|
90.40
|
3,382,076
USD
|
|
|
2017-02-01 |
2017-01-30 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
11,486
-13.0%
91.61
1,052,255
USD
|
11,486
-13.0%
|
91.61
|
1,052,255
USD
|
|
|
2017-02-01 |
2017-01-30 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
31,100
-26.1%
90.42
2,812,031
USD
|
31,100
-26.1%
|
90.42
|
2,812,031
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
8,310
-37.8%
85.25
708,461
USD
|
8,310
-37.8%
|
85.25
|
708,461
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
6,111
-21.7%
85.18
520,559
USD
|
6,111
-21.7%
|
85.18
|
520,559
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
6,111
-21.7%
85.09
519,973
USD
|
6,111
-21.7%
|
85.09
|
519,973
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
6,111
-21.7%
85.07
519,832
USD
|
6,111
-21.7%
|
85.07
|
519,832
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
8,000
-26.7%
84.94
679,504
USD
|
8,000
-26.7%
|
84.94
|
679,504
USD
|
|
|
2016-11-17 |
2016-11-15 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
8,000
-26.7%
85.01
680,096
USD
|
8,000
-26.7%
|
85.01
|
680,096
USD
|
|
|
2016-08-22 |
2016-08-19 |
S
Sale
|
BRITELL JENNE K
Non-Executive Director
|
4,000
-16.7%
84.76
339,052
USD
|
4,000
-16.7%
|
84.76
|
339,052
USD
|
|
|
2016-08-11 |
2016-08-10 |
S
Sale
|
BRITELL JENNE K
Non-Executive Director
|
4,000
-16.7%
85.20
340,808
USD
|
4,000
-16.7%
|
85.20
|
340,808
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
311
-4.9%
85.61
26,625
USD
|
311
-4.9%
|
85.61
|
26,625
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
1,747
-22.5%
85.57
149,486
USD
|
1,747
-22.5%
|
85.57
|
149,486
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
1,563
-20.6%
85.65
133,866
USD
|
1,563
-20.6%
|
85.65
|
133,866
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
800
-11.7%
85.66
68,526
USD
|
800
-11.7%
|
85.66
|
68,526
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
718
-9.5%
85.65
61,497
USD
|
718
-9.5%
|
85.65
|
61,497
USD
|
|
|
2016-08-04 |
2016-08-03 |
S
Sale
|
LEIDEN JEFFREY M
Non-Executive Director
|
1,206
-16.7%
85.62
103,263
USD
|
1,206
-16.7%
|
85.62
|
103,263
USD
|
|
|
2016-07-27 |
2016-07-25 |
S
Sale
|
ZIEGLER JOHN B
Non-Executive Director
|
1,000
-5.1%
84.36
84,359
USD
|
1,000
-5.1%
|
84.36
|
84,359
USD
|
|
|
2016-06-01 |
2016-05-27 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
23,667
-23.6%
77.26
1,828,607
USD
|
23,667
-23.6%
|
77.26
|
1,828,607
USD
|
|
|
2016-06-01 |
2016-05-27 |
PS
Planned sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
23,667
-19.1%
77.27
1,828,702
USD
|
23,667
-19.1%
|
77.27
|
1,828,702
USD
|
|
|
2016-05-16 |
2016-05-12 |
S
Sale
|
BRITELL JENNE K
Non-Executive Director
|
8,000
-40.7%
75.68
605,456
USD
|
8,000
-40.7%
|
75.68
|
605,456
USD
|
|
|
2016-05-11 |
2016-05-09 |
S
Sale
|
Cunningham Everett
SVP, Commercial
Officer
|
13,252
-29.4%
76.21
1,009,908
USD
|
13,252
-29.4%
|
76.21
|
1,009,908
USD
|
|
|
2016-05-11 |
2016-05-09 |
S
Sale
|
Cunningham Everett
SVP, Commercial
Officer
|
43,060
-57.5%
76.28
3,284,488
USD
|
43,060
-57.5%
|
76.28
|
3,284,488
USD
|
|
|
2016-05-09 |
2016-05-06 |
S
Sale
|
Cunningham Everett
SVP, Commercial
Officer
|
6,912
-17.8%
76.00
525,312
USD
|
6,912
-17.8%
|
76.00
|
525,312
USD
|
|
|
2016-05-09 |
2016-05-06 |
S
Sale
|
Cunningham Everett
SVP, Commercial
Officer
|
42,586
-57.3%
76.00
3,236,536
USD
|
42,586
-57.3%
|
76.00
|
3,236,536
USD
|
|
|
2016-05-09 |
2016-05-06 |
S
Sale
|
Cunningham Everett
SVP, Commercial
Officer
|
949
-2.9%
76.00
72,124
USD
|
949
-2.9%
|
76.00
|
72,124
USD
|
|
|
2016-04-27 |
2016-04-25 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
5,883
-7.1%
74.40
437,695
USD
|
5,883
-7.1%
|
74.40
|
437,695
USD
|
|
|
2016-04-27 |
2016-04-25 |
S
Sale
|
Doherty Catherine T.
SVP, Clin. Franchise Solutions
Officer
|
23,667
-22.3%
74.46
1,762,221
USD
|
23,667
-22.3%
|
74.46
|
1,762,221
USD
|
|
|
2016-03-03 |
2016-03-01 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
283
-0.7%
68.62
19,420
USD
|
283
-0.7%
|
68.62
|
19,420
USD
|
|
|
2016-03-03 |
2016-03-01 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
3,532
-7.7%
68.19
240,845
USD
|
3,532
-7.7%
|
68.19
|
240,845
USD
|
|
|
2015-08-13 |
2015-08-12 |
S
Sale
|
BALDWIN JOHN C MD
Non-Executive Director
|
2,266
-14.9%
72.00
163,152
USD
|
2,266
-14.9%
|
72.00
|
163,152
USD
|
|
|
2015-08-10 |
2015-08-06 |
S
Sale
|
ZIEGLER JOHN B
Non-Executive Director
|
2,200
-11.5%
74.35
163,570
USD
|
2,200
-11.5%
|
74.35
|
163,570
USD
|
|
|
2015-03-03 |
2015-03-03 |
PS
Planned sale
|
PREVOZNIK MICHAEL E
SVP & General Counsel
Officer
|
3,261
-7.2%
71.16
232,043
USD
|
3,261
-7.2%
|
71.16
|
232,043
USD
|
|
|
2015-02-12 |
2015-02-11 |
S
Sale
|
STANZIONE DANIEL
Non-Executive Director
|
8,000
-23.3%
70.97
567,755
USD
|
8,000
-23.3%
|
70.97
|
567,755
USD
|
|
|
2015-02-05 |
2015-02-04 |
S
Sale
|
WILENSKY GAIL R
Non-Executive Director
|
8,000
-29.8%
72.34
578,687
USD
|
8,000
-29.8%
|
72.34
|
578,687
USD
|
|
|
2015-02-05 |
2015-02-04 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
8,000
-32.2%
72.43
579,466
USD
|
8,000
-32.2%
|
72.43
|
579,466
USD
|
|
|
2015-02-04 |
2015-02-03 |
S
Sale
|
ZIEGLER JOHN B
Non-Executive Director
|
8,000
-32.2%
71.88
575,040
USD
|
8,000
-32.2%
|
71.88
|
575,040
USD
|
|
|
2015-02-04 |
2015-02-02 |
S
Sale
|
BONGIORNO THOMAS F
VP and Corporate Controller
Officer
|
3,000
-19.4%
71.50
214,500
USD
|
3,000
-19.4%
|
71.50
|
214,500
USD
|
|
|
2014-11-20 |
2014-11-18 |
S
Sale
|
BONGIORNO THOMAS F
VP and Corporate Controller
Officer
|
10,000
-39.4%
64.00
640,000
USD
|
10,000
-39.4%
|
64.00
|
640,000
USD
|
|
|
2014-11-18 |
2014-11-14 |
S
Sale
|
Cohen Jon R
SVP and Chief Medical Officer
Officer
|
61,877
-51.1%
63.34
3,919,258
USD
|
61,877
-51.1%
|
63.34
|
3,919,258
USD
|
|
|
2014-11-12 |
2014-11-10 |
S
Sale
|
PFEIFFER GARY M
Non-Executive Director
|
10,000
-37.2%
61.69
616,900
USD
|
10,000
-37.2%
|
61.69
|
616,900
USD
|
|
